Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Quest Diagnostics

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.

Benzinga

Despite Slump, Options Traders May be Seeing Something with Quest Diagnostics (DGX)

While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.

Barchart

What to Expect From Quest Diagnostics' Q2 2025 Earnings Report

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit growth in earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Quest Diagnostics Stock Outperforming the Nasdaq?

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Quest Diagnostics Stock Trades Near A Buy Zone; Capture Profits With This Long Call Butterfly In Options Trading

Quest Diagnostics stock is hovering in and around a buy zone. To limit risk, consider using a long call butterfly setup in options.

Investors Business Daily

Quest Diagnostics Scores Relative Strength Rating Upgrade; Hits Key Threshold

Quest Diagnostics sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock?

While Quest Diagnostics has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid Report

Quest Diagnostics stock remains a "safe haven," an analyst said Tuesday after the company topped first-quarter expectations.

Investors Business Daily

Revealed: drug tests in California prisons yielded false positives, affecting thousands of people

Records suggest Quest Diagnostics erroneously detected opiates. Lawyers say parole requests were jeopardized in the process

The Guardian - US

Here's What to Expect From Quest Diagnostics’ Next Earnings Report

Quest Diagnostics is expected to release its Q1 results this month, and analysts expect a single-digit surge in earnings.

Barchart

T-Mobile Leads Five Stocks To Watch As Market Correction Intensifies

This weekend's stocks to watch are defensive plays. They boast strong relative strength, but still suffered losses amid the market sell-off.

Investors Business Daily

Stocks To Watch: Quest Diagnostics Sees RS Rating Rise To 91

Quest Diagnostics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

Investors Business Daily

Is Quest Diagnostics Stock Outperforming the S&P 500?

Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Quest Diagnostics Scores Relative Strength Rating Upgrade

Quest Diagnostics sees its Relative Strength Rating reach the elite 90-plus level.

Investors Business Daily

Stocks With Rising Relative Price Strength: Quest Diagnostics

A Relative Strength Rating upgrade for Quest Diagnostics shows improving technical performance.

Investors Business Daily

Quest Diagnostics Shows Rising Relative Price Performance; Still Shy Of Key Threshold

A Relative Strength Rating upgrade for Quest Diagnostics shows improving technical performance. Will it continue?

Barchart

How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks?

Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Quest Diagnostics Shows Improved Relative Price Performance; Still Shy Of Benchmark

Quest Diagnostics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock?

Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know

With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth.

Barchart

Quest Diagnostics Stock: Is Wall Street Bullish or Bearish?

As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Quest Diagnostics’ Q2 2024 Earnings: What to Expect

As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Reason

Should You Be Able To Take an Alzheimer's Test at Home?

Plus, an AI-generated version of the same article

Android Central

You can help Google with its latest Fitbit study on metabolic health

Fitbit and Pixel Watch owners can participate in a metabolic health study, which involves providing digital health data and a blood sample.

1 2

People

Ronald Bailey

15 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Alzheimer Society

40 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.